CAR T-cells for AML: Where do we stand?

Current Status
Not Enrolled
Price
Free
Get Started

Sébastien Anguille

Prof. Anguille is hematologist and Head of the Division of Hematology at the Antwerp University Hospital since January 2022. He is a passionate researcher at the University of Antwerp who combines clinical work with scientific research. His research focuses on the development of new treatments for hematological diseases, such as AML, with a main focus on immune-based therapies such as CAR-T.